These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1373964)

  • 41. Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
    Kohno T; Kitamura T; Tsuda K; Ishikawa E
    J Clin Lab Anal; 1990; 4(1):74-8. PubMed ID: 1690279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
    Lee HS; Chung YH; Kim CY
    Hepatology; 1991 Jul; 14(1):68-72. PubMed ID: 1712341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alpha-fetoprotein in relation to the age of the subject. Normal and pathological levels].
    Hurjui J; Teodorovici I; Creţeanu M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):283-6. PubMed ID: 6164085
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
    Nikolić JA; Stajić M; Cuperlović M; Hajduković L; Golubović G
    J Hepatol; 1990 Sep; 11(2):252-6. PubMed ID: 1701455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later].
    Molina Infante J; Pérez Gallardo B; Prieto Bermejo AB; Fernández Bermejo M; Robledo Andrés P
    Gastroenterol Hepatol; 2007; 30(6):370-1. PubMed ID: 17662222
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 47. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
    Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
    Abdelgawad IA
    J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
    Saibara T; Maeda T; Miyazaki M; Onishi S; Yamamoto Y
    Hepatology; 1993 Aug; 18(2):315-9. PubMed ID: 7687981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis.
    Furukawa R; Tajima H; Nakata K; Kono K; Muro T; Sato A; Kawahara K; Ishii N; Kusumoto Y; Munehisa T
    Tumour Biol; 1984; 5(6):327-38. PubMed ID: 6085599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
    Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S
    Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
    Niermeijer P; Gips CH; Marrink J; QUE GS
    Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
    [No Abstract]   [Full Text] [Related]  

  • 56. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
    Niermeijer P; Gips CH; Marrink J; Qué GS
    Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.